Medical marijuana: clearing away the smoke. Grant, Igor, et al.
The Open Neurology Journal. 2012, 6: 18-25.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Leweke, F M, et al.
Translational Psychiatry. 2012 2 e94.

Cannabis – a valuable drug that deserves better treatment. Mechoulam, Raphael
Mayo Clinic Proceedings. 2012 Feb, 87(2): 107-109.

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Takeda, Shuso, et al.
Toxicol.Lett. 2012 Nov.15 214(3): 314-319.

Cannabinoid hyperemesis: a case series of 98 patients. Simonetto, D A, et al.
Mayo Clinic Proceedings. 2012 Feb, 87(2): 114-119.

Blurred boundaries: the therapeutics and politics of medical marijuana. Bostwick, Michael J
Mayo Clinic Proceedings. 2012 Feb, 87(2): 172-186.

Epigenetic regulation of fatty acid amide hydrolase in Alzheimer Disease. D’Addario, Claudio, et al.
PLoS One. 2012, 7(6): e39186.

Aroma therapy. Gardner, Fred
Medical Marijuana. 2012, 29-34.

Cannabidiol inhibits lung cancer cell invasion and metastasis. Ramer, Robert, et al.
The FASEB Journal, 2012 Apr, 1235-1248.

Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from cannabis sativa, on inflammation-induced hypermotility in mice. Izzo, Angelo, et al.
British Journal of Pharmacology. 2012 Jun, 166(4): 1444-1460.

Emerging clinical applications for cannabis and cannabinoids: a review of the recent scientific literature, 5th edition. Armento, Paul, et al.
NORML Foundation. 2012 Mar 14.

Cannabidivarin is anticonvulsant in mouse and rat. Hill, A J, et al.
British Journal of Pharmacology. 2012 Dec, 167(8): 1629-1642.

Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey(NHANES) III. Rajavashisth, Tripatith B, et al.
BMJ OPEN. 2012 2.

Naturally occurring anxiolytic substances from aromatic plants of genus citrus. Pimenta, Flavia Cristina Fernandes, et al.
Journal of Medicinal Plants Research. 2012 Jan 23, 6(3): 342-347.

The role of cannabinoids in prostate cancer: basic science perspective and potential clinical applications. Ramos, Juan A, et al.
Indian Journal of Urology. 2012 Jan, 28(1): 9-14.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptomes of schizophrenia. Leweka, F M, et al.
Translational Psychiatry. 2012, e94.

ENTER YOUR EMAIL AND GET

10% OFF

YOUR NEXT ORDER

Be the first to learn about our new product additions, events and special promotions.